Targeted Metabolomics Analysis of Serum Amino Acids in T2DM Patients

被引:2
|
作者
Bao, Li [1 ,2 ]
Wu, Bowen [3 ]
Yang, Chunjing [1 ,2 ]
Xu, Xiqiao [1 ,2 ]
Shi, Zhengyuan [1 ,2 ,4 ]
Jiang, Dechun [1 ,2 ,4 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Pharm, Beijing, Peoples R China
[2] Beijing Key Lab Biocharacterist Profiling Evaluat, Beijing, Peoples R China
[3] Tsinghua Univ, Inst TCM X, Dept Automat, Bioinformat Div,BNRIST,MOE Key Lab Bioinformat, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Shijitan Hosp, Dept Pharm, 10 Tieyi Rd, Beijing 10038, Peoples R China
基金
中国国家自然科学基金;
关键词
diabetes mellitus type 2; T2DM; targeted metabolomics; amino acids; biomarker;
D O I
10.2147/DMSO.S444987
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Amino acids are the important metabolites in the body and play a crucial role in biological processes. The purpose of this study is to provide a profile of amino acids change in the serum of T2DM patients and identify potential biomarkers.Patients and Methods: In this study, we quantitatively determined the serum amino acid profiles of 30 T2DM patients and 30 healthy volunteers. T test and multivariate statistical analysis were used to identify candidate biomarkers with GraphPad Prism 9.5 software and MetaboAnalyst 5.0 on-line platform.Results: Thirty-four amino acids were quantified, and 19 amino acid levels differed significantly between T2DM and Healthy groups. Screened by the specific screening criteria (VIP>1.0; P<0.05; FC>1.5, or FC<0.67) in MetaboAnalyst 5.0 platform, 8 amino acids were identified as potential biomarkers. Pearson rank correlation test showed 14 differential amino acids were significantly correlated with T2DM-related physiological parameters.Conclusion: The results of this study provide theoretical basis for the subsequent development of dietary supplements for the prevention or treatment of T2DM and its complications.
引用
收藏
页码:203 / 212
页数:10
相关论文
共 50 条
  • [21] Analysis of serum 25(OH)D3 levels and related factors in patients with T2DM
    Wu, Yueqin
    Wei, Jingjing
    Wang, Wei
    Liu, Yan
    Du, Jing
    Ren, Lijue
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (SUPP 2) : 66 - 66
  • [23] NAFLD prevalence in older patients with T2DM
    Kotsiliti, Eleni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (02) : 65 - 65
  • [24] ADA goals are attainable in patients with T2DM
    Hood, Robert C.
    DIABETES, 2006, 55 : A271 - A271
  • [25] NAFLD prevalence in older patients with T2DM
    Eleni Kotsiliti
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 65 - 65
  • [27] Duration of Depressive Disorders in Patients with T2DM
    De Groot, Mary K.
    Crick, Kent
    Long, Molly
    Shubrook, Jay
    DIABETES, 2016, 65 : A217 - A217
  • [28] Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients
    Li, Ling
    Wang, Chengshi
    Yang, Hongliu
    Liu, Shuyun
    Lu, Yanrong
    Fu, Ping
    Liu, Jingping
    MOLECULAR BIOSYSTEMS, 2017, 13 (11) : 2392 - 2400
  • [29] Correlation between Serum Cystatin C and PR interval Prolongation in T2DM patients
    Zhang, Yi
    Zou, Jian
    Li Guohong
    Zou, Hong
    Zhai, Jiajia
    Wang, Shujin
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
  • [30] Serum Pentosidine is Associated with Cardiac Dysfunction and Atherosclerosis in T2DM
    Cao, Yuyan
    Ye, Xinhua
    Yuan, Xiaoqing
    Liu, Juan
    Zhang, Qing
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 237 - 244